Results 181 to 190 of about 16,064,511 (322)
Abstract Perianal disease is a recognized complication of pediatric Crohn's disease (CD), but data on ulcerative colitis (UC) and inflammatory bowel disease unclassified (IBD‐U) are limited. We examined the occurrence of perianal disease before, at, and after diagnosis of pediatric‐onset IBD compared with matched (age, sex, and geographical region ...
Åsa H. Everhov +11 more
wiley +1 more source
Giant Meckel's Diverticulum Mimicking Crohn's Disease: Double-Stricture Deception. [PDF]
Li Y, He T, Wan P, Li X.
europepmc +1 more source
Abstract Objective We aimed to assess vedolizumab and ustekinumab efficacy and safety in patients with very‐early onset inflammatory bowel disease (VEO‐IBD). Methods A retrospective study involving 29 European and North American sites affiliated with the IBD Porto Group of European Society for Paediatric Gastroenterology Hepatology and Nutrition ...
Luca Scarallo +45 more
wiley +1 more source
Anti-TNF Therapy Is Associated With Browning- and Immune-Related Changes in Creeping Fat in Crohn's Disease. [PDF]
Monfort-Ferré D +15 more
europepmc +1 more source
Abstract Patients admitted for inflammatory bowel disease (IBD) are often managed by rotating teams of care providers during their hospital stay. This can lead to potential variability in the care they receive. Our team developed a scoring system of six key high‐quality care components called the standardized IBD care index (SICI) to standardize care ...
Amir Jazayeri +4 more
wiley +1 more source
Granulomatous Cheilitis as the Presenting Manifestation of Widespread Crohn's Disease. [PDF]
Nice W +3 more
europepmc +1 more source
Hair loss in pediatric inflammatory bowel disease: Clinical recognition and implications for care
Journal of Pediatric Gastroenterology and Nutrition, EarlyView.
Angela Anaeme +2 more
wiley +1 more source
Abstract Infantile‐onset inflammatory bowel disease (IOIBD) is a rare and severe subset of very‐early‐onset IBD, often associated with immune dysregulation and poor response to conventional therapies. Data regarding the use of Janus kinase inhibitors (JAKI) in this population is limited.
Smridhi Mahajan +2 more
wiley +1 more source

